Search Result "new anti-tuberculosis drugs"
New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1898-1904
Author(s): Juan Carlos Palomino, Daniela Fernandes Ramos, Pedro Almeida da Silva
New Anti-Tuberculosis Drugs with Novel Mechanisms of Action
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1956-1967
Author(s): Emma C. Rivers, Ricardo L. Mancera
Computational Biology in Anti-Tuberculosis Drug Discovery
Journal: Infectious Disorders - Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 319-326
Author(s): Dennis J. Murphy, James R. Brown
Perspectives on Tuberculosis Pathogenesis and Discovery of Anti- Tubercular Drugs
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 3 Year: 2014 Page: 3466-3477
Author(s): Fidele Ntie-Kang, Joseph N. Yong, Luc C. Owono Owono, Wolfgang Sippl, Eugene Megnassan
Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1177-1185
Author(s): Ruiru Shi, Nobunori Itagaki, Isamu Sugawara
Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 30 Year: 2013 Page: 3785-3796
Author(s): Juan Carlos Palomino,Anandi Martin
Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2016 Page: 1186-1216
Author(s): Giampietro Sgaragli,Maria Frosini
Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes
Journal: Current Pharmacogenomics
Volume: 1 Issue: 2 Year: 2003 Page: 101-109
Author(s): Bidyut Roy
Synthesis and Evaluation of Anti-Tuberculosis and Anti-Cancer Activities of Hydrazones and N-Acylhydrazones by Using Sonochemistry, A New General Procedure
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 6 Year: 2017 Page: 678-685
Author(s): Ligia Souza da Silveira Pinto,Marcus V. N. de Souza,Carlos R. Kaiser
The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 39 Year: 2014 Page: 6191-6206
Author(s): Sylvain Goutelle,Laurent Bourguignon,Pascal Maire,Roger W. Jelliffe,Michael N. Neely